-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Influenza [Strain A/H7N9] Vaccine in Influenza A Virus, H7N9 Subtype Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Influenza [Strain A/H7N9] Vaccine in Influenza A Virus, H7N9 Subtype InfectionsDrug Details:Vaccine for the avian influenza...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cell Therapy for Coronavirus Disease 2019 (COVID-19), Alopecia Areata and Type 1 Diabetes in Type 1 Diabetes (Juvenile Diabetes)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Cell Therapy For Coronavirus Disease 2019 (Covid-19), Alopecia Areata And Type 1 Diabetes in Type 1...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Adagloxad Simolenin in Triple-Negative Breast Cancer (TNBC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Adagloxad Simolenin in Triple-Negative Breast Cancer (TNBC) Drug Details:Adagloxad simolenin (OBI-222) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cell Therapy For Coronavirus Disease 2019 (COVID-19), Alopecia Areata And Type 1 Diabetes in Alopecia Areata
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cell Therapy For Coronavirus Disease 2019 (COVID-19), Alopecia Areata And Type 1 Diabetes in Alopecia...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Tobemstomig in Metastatic Renal Cell Carcinoma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Tobemstomig in Metastatic Renal Cell Carcinoma Drug Details: RG-6139 (RO-7247669) is under development for...
-
Company Profile
![]()
Netmarble Corp – Company Profile
Netmarble Corp (Netmarble) is a mobile gaming company. It carries out developing various games including Assault Gear, Blossom Party, BTS WORLD, Destiny6, Disney Magical Dice, District 187: Sin Streets, Dragon Ball Online, Dragon Striker, Everybody's Marble, Firstborn: Kingdom Come, Fishing Strike, Grandchase, GunZ: The Duel, Iron Throne, and others. The company's games are supported in android, apple, and others. It's games are used across various regions including the Americas, Europe, Asia-Pacific, Middle East, and Africa. Netmarble is headquartered in Seoul,...
Add to Basket -
Company Profile
![]()
Aristocrat Leisure Ltd – Company Profile
Aristocrat Leisure Ltd (Aristocrat) develops and distributes diversified products and services including class II and class III gaming machines and casino management systems. The company’s gaming portfolio includes RAID, Vikings, Dragon Link, Game of Thrones, Wonder 4, Dollar Storm: Buffalo Gold Revolution, Grand Star: Zorro, Timber Wolf Diamond: Cashman bingo, Choy’s Kingdom, Gold Stacks 88, The Hunt for Neptine Gold, and Lightning link. It also manufactures electronic gaming machines, social gaming and casino management systems. The company operates in online...
Add to Basket -
Company Profile
![]()
CD Projekt RED SA – Company Profile
CD Projekt RED SA (CD Projekt) is a designer, developer and publisher of role-playing video games. The product portfolio of the company includes the witcher, the witcher 2: assassins of Kings, the witcher 3: wild hunt, cyberpunk 2077, throne-breaker, the witcher tales, the witcher adventure game, went, the witcher card game. ICD Projekt also develops online multiplayer games and distributes digital video games through a wide range of online channels and digital distribution platforms directly to individual users across Russia,...
Add to Basket -
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cell Therapy for Coronavirus Disease 2019 (COVID-19), Alopecia Areata and Type 1 Diabetes
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Cell Therapy for Coronavirus Disease 2019 (COVID-19), Alopecia Areata and Type 1 Diabetes Drug...
-
Product Insights
![]()
Type 1 Diabetes (Juvenile Diabetes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Type 1 Diabetes Pipeline Drugs Market Report Overview Type 1 diabetes (T1D) occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas. The signs and symptoms of type 1 diabetes include increased thirst and frequent urination, extreme hunger, weight loss, fatigue, and irritability or unusual behavior. The Type 1 Diabetes pipeline drugs market research report provides comprehensive information on the therapeutics under development for Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders), complete with analysis by...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.